Genes Linked to Production of Secondary Metabolites in Talaromyces atroroseus Revealed Using CRISPR-Cas9 by Nielsen, Maria Lund et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 18, 2017
Genes Linked to Production of Secondary Metabolites in Talaromyces atroroseus
Revealed Using CRISPR-Cas9
Nielsen, Maria Lund; Petersen, Thomas Isbrandt; Rasmussen, Kasper Bøwig; Thrane, Ulf; Hoof, Jakob
Blæsbjerg; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro
Published in:
P L o S One
Link to article, DOI:
10.1371/journal.pone.0169712
Publication date:
2017
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Nielsen, M. L., Petersen, T. I., Rasmussen, K. B., Thrane, U., Hoof, J. B., Larsen, T. O., & Mortensen, U. H.
(2017). Genes Linked to Production of Secondary Metabolites in Talaromyces atroroseus Revealed Using
CRISPR-Cas9. P L o S One, 12(1), [e0169712]. DOI: 10.1371/journal.pone.0169712
RESEARCH ARTICLE
Genes Linked to Production of Secondary
Metabolites in Talaromyces atroroseus
Revealed Using CRISPR-Cas9
Maria Lund Nielsen, Thomas Isbrandt, Kasper Bøwig Rasmussen¤, Ulf Thrane, Jakob
Blæsbjerg Hoof, Thomas Ostenfeld Larsen, Uffe Hasbro Mortensen*
Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, Kongens
Lyngby, Denmark
¤ Current address: Novo Nordisk A/S, Niels Steensens Vej 1, Gentofte, Denmark
* um@bio.dtu.dk
Abstract
The full potential of fungal secondary metabolism has until recently been impeded by the
lack of universal genetic tools for most species. However, the emergence of several
CRISPR-Cas9-based genome editing systems adapted for several genera of filamentous
fungi have now opened the doors for future efforts in discovery of novel natural products and
elucidation and engineering of their biosynthetic pathways in fungi where no genetic tools
are in place. So far, most studies have focused on demonstrating the performance of
CRISPR-Cas9 in various fungal model species, and recently we presented a versatile
CRISPR-Cas9 system that can be successfully applied in several diverse Aspergillus spe-
cies. Here we take it one step further and show that our system can be used also in a phylo-
genetically distinct and largely unexplored species from the genus of Talaromyces.
Specifically, we exploit CRISPR-Cas9-based genome editing to identify a new gene in T.
atroroseus responsible for production of polyketide-nonribosomal peptide hybrid products,
hence, linking fungal secondary metabolites to their genetic origin in a species where no
genetic engineering has previously been performed.
Introduction
Filamentous fungi are known as prolific producers of numerous industrially important
enzymes as well as a diverse spectrum of natural products. The latter constitutes an immense
reservoir of compounds of biological and medical interest, and many products originating
from fungal secondary metabolism are used today in the pharmaceutical industry as e.g. antibi-
otics, anticancer drugs, cholesterol-lowering agents, and immunosuppressive drugs [1]. In
addition, some natural products are used commercially as pigments in cosmetics, textiles,
paints, and as natural food colorants [2].
The lack of genetic tools available for most fungal species has for many years been the
major obstacle for exploring the molecular biology and biochemistry of all but a few model
fungi. The enormous increase in sequencing projects over the past years has revealed the
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existence of an abundance of uncharacterized and often silent secondary metabolite gene clus-
ters that still awaits investigation [3]. Genetic engineering of the largely unexplored fungal spe-
cies would thus allow the full study of such gene clusters and could lead to the discovery and
characterization of new bioactive compounds.
CRISPR-Cas9-based genetic engineering has recently been implemented in Aspergillus
nidulans by us [4], and by others in several other species of filamentous fungi such as Tricho-
derma reesei [5], Neurospora crassa [6], Magnaporta oryzae [7], and Penicillium chrysogenum
[8]. Our system for A. nidulans is based on an AMA1 based vector carrying genes encoding
Cas9 and the sgRNA necessary for guiding the Cas9 endonuclease to the desired target
sequence and can potentially be used in many fungi with little or no adaptation. In fact, the
versatility of this system is demonstrated by the fact that RNA guided mutation was achieved
in six different Aspergillus species of which one was genetically engineered for the first time
[4]. Our CRISPR-Cas9 system may therefore be functional in a wide array of filamentous
fungi.
In a recent publication we reported a case of synthetic biology using A. nidulans as a host
for heterologous gene expression [9]. In this study we successfully exchanged PKS- and NRPS
modules between two related PKS-NRPS hybrids to produce the predicted combinations of
backbone polyketide-nonribosomal peptide (PK-NRP) products [9]. However, as a surprise
the synthetic polyketide-nonribosomal products contained a decalin ring system in the polyke-
tide moiety as well as an unexpected double bond in the amino acid residue side chain, instead
of the expected classical cytochalasin structure (Fig 1A and 1B). The structures of these novel
derivatives are very similar to ZG-1494α (Fig 1C), an inhibitor of platelet-activating factor
acetyltransferase isolated from two species of Talaromyces, that is T. convolutes and T. atroro-
seus [10,11].
For future synthetic biology efforts, we were therefore interested in identifying the genes
and enzymes that are required for production of this scaffold. In A. nidulans, we speculate that
the unexpected structural features in the synthetic PK-NRPs are a consequence of cross-chem-
ical reactions catalyzed by unknown endogenous enzymes provided by the host. Hence, identi-
fication of the genes in A. nidulans is not straight forward as the origin of the chemistry is
unclear. T. atroroseus, which besides ZG-1494α also produces its stereoisomer talaroconvolu-
tin A, and the analogue talaroconvolutin B (Fig 1D), has recently been sequenced [12]. Despite
that no genetic tools were available for this species prior to our work, we took advantage of this
sequence and set out to identify the genetic basis of ZG-1494α and the related compound talar-
oconvolutin A in T. atroroseus using a bioinformatics approach and our fungal CRISPR-Cas9
technology.
Fig 1. Four structurally similar polyketide-nonribosomal peptide products. Niduclavin (A) and niduporthin (B) are two novel hybrid products
produced by heterologous expression of two related PKS-NRPSs in Aspergillus nidulans [9], while ZG-1494α/talaroconvolutin B (C) and talaroconvolutin
A (D) are produced in Talaromyces atroroseus.
doi:10.1371/journal.pone.0169712.g001
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Results and Discussion
First we tested whether the CRISPR-Cas9 system that we have previously developed for
Aspergillus could be used directly in T. atroroseus. As a simple test case for Cas9 mediated gene
targeting we decided to delete the gene responsible for the green conidia pigment in T. atroro-
seus, which we hypothesized was formed from naphtha-γ-pyrone. To identify this gene we
blasted the A. nidulans- and A. niger naphtha-γ-pyrone synthase genes (wA and albA, respec-
tively) against the genome sequence of T. atroroseus. Amongst the homologous sequences
identified in this manner, UA08_00425 was the best match as judged by the size of the ORF
and by the high sequence similarities to the corresponding enzymes encoded by wA from A.
nidulans (ID: 62%; 99% query coverage) and albA from A. niger (ID: 63%; 99% query cover-
age). UA08_00425 was therefore selected for deletion.
Using our genetic tool box for fungal CRISPR-Cas9 gene editing [4], we constructed a plas-
mid containing a hph selection marker-based gene-targeting substrate designed for deleting
UA08_00425, see Fig 2A. Since the efficiency of different protospacers are known to vary sub-
stantially [13], three AMA1 based CRISPR-Cas9 vectors encoding Cas9 and one of three dif-
ferent UA08_00425 specific sgRNAs were also constructed (Fig 2A and 2B).
Unlike classical gene targeting where the ends of linear gene-targeting substrates stimulate
integration into the target site as they attract the homologous recombination (HR) repair
machinery [14]; we exploit that a specific Cas9 induced DNA double strand break (DSB) at the
target locus attracts the HR machinery [4]. As a consequence, efficient gene targeting can be
achieved by using circular gene-targeting substrates as template for repair of this DNA DSB,
hence, minimizing undesirable random integrations mediated by the non-homologous end-
joining pathway. Using this strategy for deleting UA08_00425 (Fig 2A and 2C), we investigated
Fig 2. Strategy for CRISPR-Cas9 mediated deletions in Talaromyces atroroseus. A) T. atroroseus protoplasts were co-transformed with a
circular gene-targeting substrate and an AMA1 based CRISPR-Cas9 vector containing Cas9- and sgRNA encoding genes. The transformed
protoplasts were plated on medium containing hygromycin, hence, selecting for the gene-targeting substrate only. B) Three different protospacers
were individually used to target the Cas9 endonuclease to UA08_00425. The positions are indicated by small vertical arrows. C) Depending on the
protospacer contained by Cas9, a specific DNA DSB was produced at either position 1, 2, or 3. Repair of any of these specific DNA DSBs by
homologous recombination using the circular gene-targeting substrate as repair template mediate replacement of UA08_00425 with hph.
doi:10.1371/journal.pone.0169712.g002
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the Cas9 mediated gene targeting efficiency in T. atroroseus by co-transforming the circular
vector containing the UA08_00425 gene deletion sequence with each of the three UA08_00425
specific CRISPR-Cas9 vectors. AMA1 based plasmids are readily lost in the absence of selec-
tion pressure [15] and this is also the case for our AMA1 based CRISPR plasmids (see S1 Fig).
To reduce the risk of undesired off-target effects, we therefore selected for the gene-targeting
substrate only, and not for the cas9 expressing AMA1 based plasmid, hence, confining cas9
expression to the early stages of colony development.
In two independent trials, two of the three co-transformation experiments generated
numerous colonies on solid selective medium after approximately one week, whereas the
remaining co-transformation produced only a few colonies (Fig 3A–3C and S2 Fig). Impor-
tantly, on all three transformation plates, close to all colonies formed white conidia spores in
agreement with UA08_00425 encoding the naphtha-γ-pyrone PKS. In contrast, in the absence
of Cas9, either no colonies or only green colonies were observed (Fig 3D and S2 Fig). More
importantly, the results strongly indicate that Cas9 has efficiently stimulated gene deletion
of UA08_00425 in these experiments. This conclusion is substantiated by the results of two
Fig 3. Deletion of the green pigment gene UA08_00425 in Talaromyces atroroseus using CRISPR-Cas9. A-C) Plates resulting from co-transformation
of pD-hyg-UA08_00425 and CRISPR-Cas9 vectors carrying three different protospacers, protospacer 1–3, respectively. D) T. atroroseus transformed with
gene-targeting plasmid pD-hyg-UA08_00425 (pFC574) in the absence of a CRISPR-Cas9 vector. E) T. atroroseus transformed with an AMA1-based plasmid
containing the hygromycin resistance marker hph. F) Three-point inoculation of UA08_00425Δ T. atroroseus growing on CYA.
doi:10.1371/journal.pone.0169712.g003
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control experiments. Firstly, no transformants were obtained when the circular gene-targeting
substrate was transformed alone into T. atroroseus (Fig 3D) indicating that the specific Cas9
induced DNA DSB is required for integrating information from the circular gene-targeting
substrate into the UA08_00425 locus. Secondly, no white transformants were obtained with
pFC574 carrying only the hph gene. This control experiment shows that white conidia spores
are not due to the presence of hygromycin per se (Fig 3E). Finally, we note that integration effi-
ciencies are approximately 10-fold more efficient with protospacer 1 and 2 as compared to the
efficiency obtained with protospacer 3.
Next, we streak purified six white transformants on solid medium without hygromycin
selection. In all cases, colonies remained solid white showing that the white phenotype of
transformants could be stably propagated as expected from a strain containing a permanent
gene deletion (Fig 3F). In agreement with this conclusion, we confirmed that UA08_00425
was eliminated in all six purified strains by tissue-PCR (S3 Fig and S5 Fig). Since deletion of
UA08_00425 results in white conidia spores, we have named this gene albA (S1 Appendix).
The efficient CRISPR-Cas9 mediated deletion of albA in T. atroroseus prompted us to iden-
tify the genetic origin of ZG-1494α and its derivative talaroconvolutin A (Fig 1).The structures
of these compounds appear to be fusions of highly reduced polyketide moieties to tyrosine res-
idues, similar to what is seen for example in cytochalasins and chaetoglobosins [16]. Therefore,
we suspected that a homolog of ccsA, the PKS-NRPS-encoding gene linked to cytochalasin
production in A. clavatus [17], is responsible for the biosynthesis of a common backbone for
these compounds. In support of this view, the nitrogen-containing tetramic acid moiety pres-
ent in both compounds is a common structural feature for several known PKS-NRPS products
such as preaspyridone, pretenellin A, prepseurotin, as well as niduclavin, and niduporthin
[9,18–20]. Due to the structural resemblance between the niduclavin backbone and the back-
bone of the talaroconvolutins/ZG1494α, we blasted the ccsA gene against the T. atroroseus
genome, to identify PKS-NRPS-encoding genes in T. atroroseus. Based on this analysis we
selected the gene with the highest sequence identity, UA08_04451 (ID: 46.0%, 96% query cov-
erage) for deletion.
A gene-targeting substrate for deletion of UA08_04451 was constructed and co-trans-
formed with a CRISPR-Cas9 plasmid carrying a sgRNA targeting UA08_04451. After approxi-
mately one week, green colonies appeared on solid hygromycin selection medium (Fig 4A).
Importantly, no transformants appeared when the gene-targeting substrate was transformed
Fig 4. Deletion of UA08_04451 (talA), encoding a hybrid PKS-NRPS, in Talaromyces atroroseus using CRISPR-Cas9. A) Co-transformation of gene-
targeting plasmid pD-hyg-talA with a CRISPR-Cas9 vector. B) T. atroroseus transformed with pD-hyg-talA in the absence of a CRISPR-Cas9 vector. C)
UHPLC-HRMS analysis of the extracts of wild type (WT) T. atroroseus along with a T. atroroseus talA deletion strain. Shown are EIC @ 528.3084 (±0.0100)
for ZG-1494α (i), and EIC @ 510.2979 (±0.0100) for talaroconvolutin A (ii). We suspect the two peaks in (i) to represent both ZG-1494α and talaroconvolutin
B. Note that EICs are based on [M+Na]+ adducts.
doi:10.1371/journal.pone.0169712.g004
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without a CRISPR-Cas9 plasmid strongly indicating that formation of the transformants
required Cas9 activity (Fig 4B). Eight colonies were streak purified on solid CYA medium
supplemented with hygromycin and were subsequently analyzed by tissue PCR. The PCR
results confirmed the deletion of UA08_04451 for at least seven out of the eight streak purified
candidates (S4 Fig and S5 Fig). The seven UA08_04451 deletion strains were analyzed by
UHPLC-HRMS and in all cases production of both talaroconvolutin A and ZG-1494α was
abolished (Fig 4C). Together these results strongly indicate that talaroconvolutin A and ZG-
1494α are formed from a common PK-NRP backbone synthesized by a PKS-NRPS fusion
enzyme encoded by UA08_04451, and we have therefore named this gene talA (S2 Appendix).
Conclusions
In this study we have used CRISPR-Cas9 technology to genetically engineer T. atroroseus and
used it to explore the secondary metabolism of this fungus. Specifically, we have identified a
novel gene encoding a hybrid PKS-NRPS, which is responsible for production of medically rel-
evant ZG-1494α. To the best of our knowledge, this represents the first example of reverse
genetic engineering of a Talaromyces species. Importantly, the fact that our CRISPR-Cas9 sys-
tem, which we have originally developed for gene editing of Aspergillus species, can be used
without any modifications to engineer a phylogenetically distinct species, raises the possibility
that it can also be used directly in a wide range of other fungal species.
Materials and Methods
Strains, genomic DNA, and media
T. atroroseus strain IBT 11181 was obtained from the IBT Culture Collection at Department
of Biotechnology and Biomedicine at Technical University of Denmark. It is also deposited
in the CBS collection at CBS-KNAW, the Netherlands, as CBS 123796 and CBS 238.95. The
T. atroroseus genome sequence has been deposited at DDBJ/ENA/GenBank under the acces-
sion LFMY00000000. The version described in this paper is version LFMY01000000. DNA
sequences of T. atroroseus genes albA and talA are presented in S1 Appendix and S2 Appendix,
respectively. Genomic DNA (gDNA) from T. atroroseus was extracted using the FastDNATM
SPIN Kit for Soil DNA extraction (MP Biomedicals, USA), and T. atroroseus gDNA was used
as PCR template for amplification of the up- and downstream fragments for deletion of talA
(UA08_04451) and the green pigment gene (UA08_00425). T. atroroseus was cultivated in liq-
uid- and on solid CYA medium (Czapek yeast autolysate) supplemented with 300 μg/ml
hygromycin B (Hygrogold, Invivogen) when needed. Escherichia coli strain DH5α was used
for plasmid propagation.
Vector construction
PCR fragments were amplified using the PfuX7 polymerase [21] with primers purchased from
Integrated DNA Technology, Belgium (S1 Table). Construction of vectors was carried out by
Uracil-Specific Excision Reagent (USER) fusion of PCR fragment into compatible plasmids
[22]. The deletion plasmids pD-hyg-talA and pD-hyg-albA were constructed by amplification
of approximately 2-kb up- and downstream fragments followed by cloning into two distinct
PacI/Nt.BbvCI USER cassettes located on each side of the hygromycin resistance gene. The
sgRNA was introduced into the CRISPR-Cas9 vector pFC330 via the tails of two primers as
described by Nødvig et al. [4]. Plasmids were purified using the GenEluteTM Plasmid Miniprep
Kit (Sigma-Aldrich), and verified by restriction analysis. A list of all plasmids from this study
is presented in S2 Table. Deletions were achieved using the CRISPR-Cas9 system described by
CRISPR-Cas9 Gene Editing in Talaromyces atroroseus
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Nødvig et al. [4]. A circular deletion plasmid (gene-targeting substrate) was co-transformed
with an AMA1-based CRISPR-Cas9 vector containing the guide RNA and the Streptococcus
pyogenes cas9 gene codon optimized for A. niger. The CRISPR-Cas9 vector also contained the
pyrG auxotrophic marker; however, only the deletion plasmid, containing the hygromycin
resistance gene, was selected for during transformation.
Protoplastation and transformation
Protoplastation of T. atroroseus was achieved using protocols described previously for A. nidu-
lans [23,24]. For transformation, 2.5–3 μg DNA of the deletion plasmid and 2.5–3 μg DNA of
the CRISPR-Cas9 vector were mixed with 100 μl protoplasts. 100 μl of a solution of 40% PEG
in 1 M sorbitol, 50 mM Tris, 10 mM CaCl2, pH 7.5 was added and the sample was incubated
on ice for 15 min. Another 500 μl of the PEG solution was added followed by incubation at
room temperature for another 15 min. The mixture was then added to 8 ml molten soft (0.8%
agar) CYA medium supplemented with 1 M sorbitol and spread on solid CYA plates supple-
mented with 1 M sorbitol (2% agar). The plates were incubated O/N at 30˚C, and the next day
overlaid with 8 ml soft CYA medium supplemented with 300 μg/ml hygromycin. The plates
were incubated at 30˚C until transformants appeared on the transformation plates (approxi-
mately 1 week). Transformants were re-streaked on CYA plates containing the same antibiotic
concentration. Tissue-PCR as described by Nødvig et al. [4] was used for strain validation
(see S3 Fig and S4 Fig). Two sets of primers were used to validate the deletions of talA and
the green pigment gene. In one reaction the reverse primer would bind in the promoter of
the marker (PgpdA) while the forward primer would bind outside the upstream targeting
sequence. In another reaction designed to check for negatives or possible heterokaryons the
forward primer would bind in the upstream targeting sequence while the reverse primer
would bind inside the gene.
Chemical analysis of T. atroroseus strains
Validated T. atroroseus strains were grown for 7 days on CYA plates and plug extractions were
performed as described by Smedsgaard [25] with the exception that secondary metabolites
were extracted with 3:1 ethylacetate:isopropanol containing 1% formic acid. Ultra-high Perfor-
mance Liquid Chromatography-High Resolution Mass Spectrometry (UHPLC-HRMS) was
performed on an Agilent Infinity 1290 UHPLC system (Agilent Technologies, Santa Clara,
CA, USA) equipped with a diode array detector. Separation was obtained on an Agilent Poro-
shell 120 phenyl-hexyl column (2.1 × 250 mm, 2.7 μm) with a linear gradient consisting of
water (A) and acetonitrile (B) both buffered with 20 mM formic acid, starting at 10% B and
increased to 100% in 15 min where it was held for 2 min, returned to 10% in 0.1 min and
remaining for 3 min (0.35 mL/min, 60˚C). An injection volume of 1 μL was used. MS detection
was performed in positive detection on an Agilent 6545 QTOF MS equipped with Agilent
Dual Jet Stream electrospray ion source with a drying gas temperature of 250˚C, gas flow of 8
L/min, sheath gas temperature of 300˚C and flow of 12 L/min. Capillary voltage was set to
4000 V and nozzle voltage to 500 V. Mass spectra were recorded at 10, 20 and 40 eV as centroid
data for m/z 85–1700 in MS mode and m/z 30–1700 in MS/MS mode, with an acquisition rate
of 10 spectra/s. Lock mass solution in 70:30 methanol:water was infused in the second sprayer
using an extra LC pump at a flow of 15 μL/min using a 1:100 splitter. The solution contained
1 μM tributylamine (Sigma-Aldrich) and 10 μM Hexakis(2,2,3,3-tetrafluoropropoxy)phospha-
zene (Apollo Scientific Ltd., Cheshire, UK) as lock masses. The [M + H]+ ions (m/z 186.2216
and 922.0098 respectively) of both compounds was used. Extracted ion chromatograms were
used to evaluate the production of ZG-1494α and talaroconvolutin A.
CRISPR-Cas9 Gene Editing in Talaromyces atroroseus
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